Why One Korean Biotech Picked New Jersey for U.S. Headquarters

Jul 05, 2018

Ki-Young Sohn, chairman and CEO of Enzychem Lifesciences, explains why the company selected New Jersey as the location for their U.S. offices.

He spoke to Pharm Exec during a company event in New York City.

 

native1_300x100
lorem ipsum